# Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)

> **NCT00086463** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 60 (—)

## Conditions studied

- Pulmonary Arterial Hypertension
- Ayerza Syndrome
- Pulmonary Hypertension

## Interventions

- **DRUG:** Iloprost or placebo

## Key facts

- **NCT ID:** NCT00086463
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 60 (—)
- **Last updated:** 2011-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086463, "Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00086463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*